kabutan

K Pharma, The Current Fiscal Year's Net Income to Widen

Thu Feb 12, 2026 3:00 pm JST Earnings

4896 K Pharma,Inc. 【J-GAAP】

Earnings Report

K Pharma,Inc. <4896> [TSE Growth] announced its financial results in the afternoon session on February 12th (15:00). The net loss (non-consolidated) for the fiscal year ended December 2025 expanded to a loss of 0.99 billion yen (compared to a loss of 0.84 billion yen in the previous period). For the fiscal year ending December 2026, the net loss is expected to be loss of 1.61 billion yen. This will mark the third consecutive term of losses.

In the most recent three-month period, from October to December (4Q), the net loss expanded to loss of 0.31 billion yen (compared to a loss of 0.22 billion yen in the same period last year).

Kabutan News

Actual Results

Historical Performance
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Dec, 2023 1,000 366 344 260 25.4 0 Feb 14, 2024 J-GAAP
Dec, 2024 0 -836 -836 -846 -72.9 0 Feb 13, 2025 J-GAAP
Dec, 2025 0 -916 -920 -993 -85.6 0 Feb 12, 2026 J-GAAP
YoY － -9.6% -10.0% -17.4% -17.3%

Full Year Results vs. Previous Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Dec, 2025 Guidance ー -1,123 -1,122 -1,136 -97.9 0 Jul 14, 2025 J-GAAP
Dec, 2025 Results 0 -916 -920 -993 -85.6 0 Feb 12, 2026 J-GAAP
Revision Rate － +18.4% +18.0% +12.6% +12.6%

Current Period Guidance

H1 Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Jan - Jun, 2025 0 -437 -437 -444 -38.3 0 Aug 14, 2025 J-GAAP
Jan - Jun, 2026 Guidance ー -660 -675 -684 -58.9 0 Feb 12, 2026 J-GAAP
YoY － -51.0% -54.5% -54.1% -53.6%

Current Period Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Dec, 2024 0 -836 -836 -846 -72.9 0 Feb 13, 2025 J-GAAP
Dec, 2025 0 -916 -920 -993 -85.6 0 Feb 12, 2026 J-GAAP
Dec, 2026 Guidance ー -1,520 -1,550 -1,616 -139.0 0 Feb 12, 2026 J-GAAP
YoY － -65.9% -68.5% -62.7% -62.4%

Quarterly Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Operating Profit Margin Announce Accounting Standards
Oct - Dec, 2024 0 -216 -217 -222 -19.1 -Inf Feb 13, 2025 J-GAAP
Jan - Mar, 2025 0 -198 -198 -199 -17.2 -Inf May 15, 2025 J-GAAP
Apr - Jun, 2025 0 -239 -239 -245 -21.2 -Inf Aug 14, 2025 J-GAAP
Jul - Sep, 2025 0 -231 -229 -237 -20.5 -Inf Nov 12, 2025 J-GAAP
Oct - Dec, 2025 0 -248 -254 -312 -26.9 -Inf Feb 12, 2026 J-GAAP
YoY － -14.8% -17.1% -40.5% -40.5%

Related Articles